. 2020 Jan 17;27(4):R79–R92. doi: 10.1530/ERC-19-0476
This work is licensed under a Table 2.
Performance of different modalities in the localization of insulinomas.
| Sensitivity | Referencesa | |
|---|---|---|
| MRT | 56–90% | (Morganstein et al. 2009, Luo et al. 2016, Wei et al. 2016, Zhu et al. 2017, Antwi et al. 2018, Fu et al. 2018) |
| Multiphase CT | 44–74% | (Morganstein et al. 2009, Tavcar et al. 2014, Imperiale et al. 2015, Téllez-Ávila et al. 2015, Luo et al. 2016, Moreno-Moreno et al. 2016, Morera et al. 2016, Prasad et al. 2016, Wei et al. 2016, Zhu et al. 2017, Antwi et al. 2018, Fu et al. 2018, Nakuz et al. 2018, Andreassen et al. 2019, Boss et al. 2019) |
| EUS | 70–100% | (Morganstein et al. 2009, Tavcar et al. 2014, Imperiale et al. 2015, Téllez-Ávila et al. 2015, Luo et al. 2016, Moreno-Moreno et al. 2016, Morera et al. 2016, Prasad et al. 2016, Wei et al. 2016, Zhu et al. 2017, Antwi et al. 2018, Fu et al. 2018, Nakuz et al. 2018, Andreassen et al. 2019, Boss et al. 2019) |
| ASVS | 65–100% | (Morganstein et al. 2009, Tavcar et al. 2014, Imperiale et al. 2015, Téllez-Ávila et al. 2015, Luo et al. 2016, Moreno-Moreno et al. 2016, Morera et al. 2016, Prasad et al. 2016, Wei et al. 2016, Zhu et al. 2017, Antwi et al. 2018, Fu et al. 2018, Nakuz et al. 2018, Andreassen et al. 2019, Boss et al. 2019) |
| SSTR SPECT/CT | 20–33% | (Morganstein et al. 2009, Tavcar et al. 2014, Imperiale et al. 2015, Téllez-Ávila et al. 2015, Luo et al. 2016, Moreno-Moreno et al. 2016, Morera et al. 2016, Prasad et al. 2016, Wei et al. 2016, Zhu et al. 2017, Antwi et al. 2018, Fu et al. 2018, Nakuz et al. 2018, Andreassen et al. 2019, Boss et al. 2019) |
| SSTR PET /CT | 61–87% | (Prasad et al. 2016, Boss et al. 2019) |
| GLP-1R SPECT/CT | 69% | (Antwi et al. 2018) |
| GLP-1R PET/CT | 94–98% | (Luo et al. 2016, Antwi et al. 2018) |
| 18F-DOPA PET/CTb | 50–73% | (Imperiale et al. 2015, Nakuz et al. 2018) |
Table 2 summarizes the performance of different modalities in the localization of insulinomas.
aReferences include all English written literature not older than 6 years with more than 12 patients using the following keywords: respective localization modality and insulinoma or endogenous hyperinsulinemic hypoglycemia. bStudies with less than 12 insulinoma patients were included here since larger 18F-FDOPA PET/CT studies are not performed yet.